In response to the USFDA inspection conducted at ZydusLifesciences Limited's Moraiya, Ahmedabad manufacturing facility from 23rd to 27th January 2023, the Zydus Group has received the Establishment Inspection Report (EIR). Transdermal patches were inspected as part of a PAI. It ended with NIL observations.

Zydus Group manufactures various pharmaceutical products, including formulations, APIs, vaccines, biosimilars, complex products (transdermal, topical, etc.), animal health products, and wellness products.